Tesamorelin 2mg 1 vial Euro Pharmacies


Tesamorelin is a synthetic growth hormone releasing hormone analogue used in the treatment of visceral adiposity in human immunodeficiency virus (HIV) infected patients with lipodystrophy. Tesamorelin is administered subcutaneously and has major effects on glucose and lipid metabolism, but has not been linked to elevations in serum aminotransferase during treatment or to cases of clinically apparent acute liver injury.



Tesamorelin is a synthetic polypeptide that acts on growth hormone-producing cells in the pituitary gland and is usually metabolized locally by receptor-bearing cells. As a polypeptide, tesamorelin is unlikely to have direct cytotoxicity. Allergic responses to its administration did not elicit hepatic or systemic hypersensitivity responses.
The recommended dose is 2 mg per day administered by subcutaneous injection. Side effects are not common but may include injection site reactions, itching, arthralgia, myalgia and peripheral edema. Tesamorelin increases IGF-1 levels and monitoring for elevations during treatment is recommended. Potential and rare adverse events include stimulation of malignant tumor growth, glucose intolerance, diabetes, and hypersensitivity reactions.


There are no reviews yet.

Be the first to review “Tesamorelin 2mg 1 vial Euro Pharmacies”

Your email address will not be published. Required fields are marked *